A Multi-centre Long Term Follow-up Study to Assess the Durability of Sustained Virologic Response in Alisporivir-treated Chronic Hepatitis C Patients
A Multi-centre Long Term Follow-up Study to Assess the Durability of Sustained Virologic Response in Alisporivir-treated Chronic Hepatitis C Patients
The purpose of this study is to follow-up with participants from feeder studies who achieved sustained virologic response (SVR) over 24 hours posttreatment (SVR24), to assess durability of SVR, and to assess the changes in liver disease, development of hepatocellular carcinoma and post-treatment safety over time.
Participants enter this study from feeder studies CDEB025A2210 (NCT01183169), CDEB025A2301 (NCT01318694), and CDEB025A2211 (NCT01215643). They return to the site for up to 48 weeks with a maximum of 3 visits. No treatment is involved.
Inclusion Criteria:
Exclusion Criteria:
Buenos Aires, Buenos Aires C1125ABE, Argentina
Buenos Aires, Buenos Aires C1405BCK, Argentina
Torono, Ontario M5G 2C4, Canada
Hyderabad, Andhra Pradesh 500012, India
Lódz, 91-347, Poland
Niaosong Township, 83301, Taiwan
Fatih / Istanbul, 34098, Turkey (Türkiye)
Glasgow - Scotland, G12 OYN, United Kingdom